Whitehall-Robins to market softgel Advil through agreement with Scherer.
This article was originally published in The Tan Sheet
Executive Summary
WHITEHALL TO MARKET SOFTGEL ADVIL THROUGH AGREEMENT WITH SCHERER giving Whitehall-Robins the rights to market an Advil product using Scherer's patented Enhanced Solubility System (ESS). The license and supply agreement, under which Scherer is getting an undisclosed up-front payment as well as manufacturing revenues and product royalties, was announced by the companies May 6.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: